Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Envelope glycoprotein 120 (gp120) is a surface-exposed glycoprotein of the human immunodeficiency virus type 1 (HIV-1). It is essential for viral entry into host cells, mediating attachment to specific cell surface receptors (CD4 and CCR5 or CXCR4) and initiating the fusion process required for infection. It is a challenging vaccine target due to its heavy glycosylation, structural flexibility, and conformational masking.
Target of neutralizing antibodies; involved in viral entry, thus drugs could target its interaction with CD4 or co-receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Envelope Glycoprotein 120 (HIV-1) (gp120).